About Palafer
Palafer was founded in 2017 and is based in Monteregie, Canada. Operations are centered in the pharmaceutical sector, where iron deficiency treatments are produced. The company focuses on developing and manufacturing specialized drugs to address anemia and related conditions. Distribution occurs primarily through healthcare channels in Canada, with emphasis on regulatory compliance and quality standards in drug production.
- Headquarter Monteregie, Canada
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Palafer
Detailed funding history for Palafer
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Palafer
Palafer has secured backing from 1 investor. Prominent investors backing the company include Mylan.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Mylan, part of Viatris, is focused on healthcare solutions.
|
Locked | Locked | Locked |
Investor details for Palafer
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Palafer
Investment portfolio details for Palafer
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Palafer
Detailed financials for Palafer
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Palafer Comparisons
Peer comparison for Palafer
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Palafer
Detailed competitors of Palafer
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Palafer
Complete news archive for Palafer
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Palafer
Palafer was founded in 2017.
Palafer is headquartered in Canada.
Palafer was founded in 2017 and is based in Monteregie, Canada. Operations are centered in the pharmaceutical sector, where iron deficiency treatments are produced. The company focuses on developing and manufacturing specialized drugs to address anemia and related conditions. Distribution occurs primarily through healthcare channels in Canada, with emphasis on regulatory compliance and quality standards in drug production.
Palafer has 1 investor. Key investors include Mylan.